Bei Liu
Beijing, Beijing Municipality, 100053, China
NCT Number: NCT03665792
This study purpose to observation the sevoflurane analgesia effect, and using nociception real-time monitoring NOX to test the correlation between the sevoflurane and NOX index.
Looking for future studies?
Notify Me25 year–85 year
All sexes
Observational
Beijing, Beijing Municipality, 100053, China
This study purpose to observation the sevoflurane analgesia effect, and using nociception real-time monitoring NOX to test the analgesia effect of the sevoflurane.
And test the correlation between the sevoflurane and NOX index.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
non-invasive, real time, monitoring for nociception stimulation
Other names: CON , BIS
Time frame: through study completion, an average of 1 year
The sevoflurane application correlated with the qNOX index, meanwhile reflect the analgesia effect of sevoflurane application
China International Neuroscience Institution
Other
The Prospective Observational Research of the Analgesic Effect of Sevoflurane and the Correlation Between Sevoflurane and qNOX
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03841812
Analgesic Adverse Reaction, Inhalant Use
Beijing, Beijing Municipality, China
View Trial DetailsNCT05575700
Acute Pain, Agnosia
Brøndby, Denmark
View Trial DetailsNCT04369222
Analgesic Adverse Reaction, Gonad Regulating Hormone Adverse Reaction
Copenhagen, Denmark
View Trial DetailsNCT05924412
Acute Pain, Agnosia
Santiago, Metropolitan, Chile
View Trial Details